Generic placeholder image

Current Women`s Health Reviews

Editor-in-Chief

ISSN (Print): 1573-4048
ISSN (Online): 1875-6581

Review Article

Current Trends and Future Strategies on Diagnosis and Management of Adenomyosis: An Updated Review

In Press, (this is not the final "Version of Record"). Available online 11 March, 2024
Author(s): Rizwana Bee*, Mohammad Ahmad, Shashi Verma and Ritesh Kumar Tiwari
Published on: 11 March, 2024

Article ID: e110324227857

DOI: 10.2174/0115734048265172231018071749

Price: $95

Abstract

This aim of the study was to gather information for use in the present and future management of the adenomyosis condition. Adenomyosis is a benign gynecological condition that needs to be managed for the rest of one's life with either medication or surgical treatment. It is also associated with abnormal uterine bleeding, dysmenorrhea, dyspareunia, and infertility. The choice a woman makes will be influenced by her age, reproductive status, and clinical indicators. The primary goals of this study were to gain knowledge on adenomyosis and to review potential treatment possibilities. According to this review, adenomyosis can be treated in a number of ways, including through medical attention utilizing least-invasive techniques a surgical operation that is performed with minimally invasive techniques. Focused ultrasound with high intensity (HIFU) for hysteroscopic ablation and resection Embolishing the uterine artery (UAE). Adenomyosis is a benign gynecological illness that necessitates a lifelong care strategy by medication or surgical therapy and is accompanied by abnormal uterine hemorrhage, dysmenorrhea, dyspareunia, and infertility. The option a woman chooses will depend on her age, reproductive status, and clinical signs. Since there is currently no medication approved for the treatment of adenomyosis, the present review will focus on existing and future medical procedures for the condition. The uterus is impacted by the medical condition adenomyosis. It happens when the endometrial tissue that normally lines the uterus invades the myometrium, the uterine muscle wall. Although this illness is benign, some people may experience substantial pain and discomfort as a result of it. It is more typically detected in those who have had children and is most frequently diagnosed in people between the ages of 30 and 50. Treatment options depend on the severity of symptoms and the individual's specific situation. Treatment approaches may include Pain Management, Hormonal Therapy, Surgical Interventions, Surgical Interventions and Lifestyle Changes. Several uterine-sparing therapeutic alternatives are currently available, each with unique risks and benefits, such as medication, hysteroscopic resection or ablation, conservative surgical methods, and high-intensity focused ultrasound. Uterine artery embolization, a practical, secure, and cost-effective method for treating uterine fibroids, has recently grown in popularity as a treatment for uterine adenomyosis.


Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy